Tocris Bioscience
Welcome to Tocris

| Advanced Search
Home Products Technical Support Customer Support Literature Custom Synthesis
Category: Nuclear ReceptorsarrowRetinoic Acid Receptors
Cat.No. Product Name
1396 Fenretinide
Alternative name(s): 4-HPR
Price and Availability

Click here for full price details of
Fenretinide
Chemical Name: N-(4-Hydroxyphenyl)retinamide

Biological Activity:

Synthetic retinoid agonist. Antiproliferative, antioxidant and anticancer agent with a long half-life in vivo. Apoptotic effects appear to be mediated by a mechanism distinct from that of 'classical' retinoids.

Technical Data:

Click here for more information on batch specific data
M.Wt: 391.55
Formula: C26H33NO2
Storage: Store at -20°C
Solubility: Soluble to 100 mM in Ethanol and to 100 mM in DMSO
CAS No: [65646-68-6]

Resources:

  • Certificate of Analysis / MSDS:

    Certificate of Analysis: View current batch
    For specific/earlier batch please select:  
    Product/Material Safety Data Sheet: View current batch
    For specific/earlier batch please select:  

    References:

    Ulukaya and Wood (1999) Fenretinide and its relation to cancer. Cancer Treat.Rev. 25 229. Takahashi (2000) Antioxidant properties of N-(4-hydroxyphenyl)retinamide (fenretinide). Biol.Pharm.Bull. 23 222. Le Doze et al (2000) Pharmacokinetics of all-trans retinoic acid, 13-cis retinoic acid, and fenretinide in plasma and brain of rat. Drug Metab.Disp. 28 205.
    View related products by Pharmacological Action or by Research Area

    Keywords: Fenretinide, Retinoic Acid Receptors, Synthetic Retinoid. Potent Anti-cancer Agent, 4-HPR, Tocris Bioscience

    New Product Guide
    Tocris Bioscience. Our latest New Product Guide highlights over 140 new productsOur latest New Product Guide highlights over 140 new products.
    Request Copy / View PDF
    Featured New Product
    Cytochrome P450 inhibitor
    2705   Liarozole
    Cytochrome P450 inhibitor. Inhibits several cytochrome P450 enzymes including aromatase (CYP19) and retinoic acid 4-hydroxylase (CYP26). Blocks retinoic acid metabolism (retinoic acid metabolism blocking agent, RAMBA). Displays antitumoural activity against androgen-dependent and independent rat prostate carcinomas.
    View all Featured New Products
    New Products in this Area

     2852Adapalene
     RARβ and RARγ agonist
     2705Liarozole hydrochloride
     Blocks retinoic acid metabolism
     2554CD 1530
     Potent and selective RARγ agonist
    Sign-up for new product e-alerts
    Log In / Register

    User ID
    Password
    If you are not registered with us Create Account